×
Thursday, October 2, 2025

Author

NewsService

News Service

atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial for Its Sol-gel Based Direct-to-Brain Drug Delivery Technology

Tue, Oct 18, 2022 08:25 ET

Let's Talk Interactive Brings in Chief Financial Officer Alexander Monroe

Tue, Oct 18, 2022 08:25 ET

Tecnoglass Sets Date for Third Quarter 2022 Results

Tue, Oct 18, 2022 08:25 ET

New Owler Report Shows 72% of Workforce Plans to Stay at Current Company

Tue, Oct 18, 2022 08:25 ET

mergex Confirms Synthesis of a CD8+ T cell Adaptive Vaccine for Smallpox and Monkeypox

Tue, Oct 18, 2022 08:25 ET

OTC Markets Group Welcomes Dream Residential Real Estate Investment Trust to OTCQX

Tue, Oct 18, 2022 08:25 ET

Zai Lab to Announce Third Quarter 2022 Financial Results on November 9, 2022

Tue, Oct 18, 2022 08:25 ET

AnPac Bio Announces Plan to Implement ADS Ratio Change

Tue, Oct 18, 2022 08:25 ET

Kalera to Divest Seed Genetics Business and International Assets

Tue, Oct 18, 2022 08:25 ET

LEXEO Therapeutics Receives Orphan Drug Designation for LX1004 from European Commission

Tue, Oct 18, 2022 08:25 ET

Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the Hippo Pathway

Tue, Oct 18, 2022 08:25 ET

Weatherford Enters into $370 Million Amended and Restated Credit Facility

Tue, Oct 18, 2022 08:25 ET
© SubmitMyPR All Rights Reserved 2012 - 2025